Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2 Ovarian Neoplasms 1 Neoplasms 1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1 Liver Neoplasms 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Anxiety Disorders 1

Interventions

Sorafenib 42 Bevacizumab 26 Oxaliplatin 21 Radiosurgery 19 Gemcitabine 17 Fluorouracil 15 Hepatectomy 13 lenvatinib 12 Radiofrequency Ablation 11 Nivolumab 11 Cisplatin 11 Radiotherapy 10 Doxorubicin 10 Capecitabine 10 durvalumab 9 Leucovorin 9 Blood Specimen Collection 9 atezolizumab 8 Liver Transplantation 8 Everolimus 7 Electroporation 7 pembrolizumab 6 camrelizumab 6 Sunitinib 6 Immunohistochemistry 6 Cryosurgery 6 Carboplatin 6 tremelimumab 5 sintilimab 5 apatinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Neoplasms × Glutamyl Aminopeptidase × Clear all

NCT05713994 2025-03-25

CCGLC-001

Tongji Hospital

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡